Ticker > Company >

Aakaar Medical Techn share price

Aakaar Medical Technologies Ltd.

NSE: AAKAAR SECTOR: Trading  641   0   0

92.55
+5.05 (5.77%)
NSE: 05 Sep 03:31 PM

Price Summary

Today's High

₹ 94

Today's Low

₹ 86.55

52 Week High

₹ 105

52 Week Low

₹ 62

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

131.17 Cr.

Enterprise Value

148.36 Cr.

No. of Shares

1.42 Cr.

P/E

21.72

P/B

2.61

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  35.42

CASH

5.55 Cr.

DEBT

22.74 Cr.

Promoter Holding

-

EPS (TTM)

₹  4.26

Sales Growth

33.55%

ROE

33.81 %

ROCE

26.62%

Profit Growth

110.42 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year33.55%
3 Year46.8%
5 YearNA

Profit Growth

1 Year110.42%
3 Year55.11%
5 YearNA

ROE%

1 Year33.81%
3 Year28.01%

ROCE %

1 Year26.62%
3 Year25.24%

Debt/Equity

0.98

Price to Cash Flow

-24.26

Interest Cover Ratio

5.7271

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List
 Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 46.8014568600799% for the Past 3 years.
  • Company has been maintaining healthy ROE of 28.0138333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 25.2405333333333% over the past 3 years.

 Limitations

  • Company has negative cash flow from operations of -5.4063.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 19.47 32.78 46.11 61.58
Total Expenditure 17.07 29.26 41.11 51.85
Operating Profit 2.4 3.53 5 9.74
Other Income 0.04 0.09 0.16 0.18
Interest 0.21 0.43 1.14 1.71
Depreciation 0.02 0.09 0.14 0.12
Exceptional Items 0 0 0 0
Profit Before Tax 2.2 3.1 3.89 8.08
Tax 0.59 0.95 1.02 2.04
Net Profit 1.62 2.15 2.87 6.04
Adjusted EPS (Rs.) 1.69 2.25 3 5.79

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.7 0.7 0.7 10.42
Total Reserves 7.33 8.96 11.84 12.78
Borrowings 0 0 0 0
Other N/C liabilities 0.32 0.4 1.59 2.55
Current liabilities 9.45 12.91 20.64 29.96
Total Liabilities 17.8 22.97 34.77 55.71
Assets
Net Block 0.2 0.36 0.28 0.24
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 0
Investments 0 0 0 0
Loans & Advances 0.11 0.16 1.45 3.01
Other N/C Assets 0.16 0.22 0.23 0.61
Current Assets 17.33 22.22 32.81 51.85
Total Assets 17.8 22.97 34.77 55.71
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 2.2 3.1 3.89 8.08
Adjustment 0.17 0.83 1.06 1.58
Changes in Assets & Liabilities -1.25 -5.82 -11.73 -13.08
Tax Paid -0.64 -1.04 -1.26 -1.99
Operating Cash Flow 0.48 -2.93 -8.04 -5.41
Investing Cash Flow -0.23 -0.32 -0.04 -0.05
Financing Cash Flow -0.81 1.17 8.19 10.71
Net Cash Flow -0.55 -2.08 0.11 5.25

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Aakaar Medical Techn Stock Price Analysis and Quick Research Report. Is Aakaar Medical Techn an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Aakaar Medical Techn. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Aakaar Medical Techn has a PE ratio of 21.71872433295 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Aakaar Medical Techn has ROA of 13.3501% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Aakaar Medical Techn has a Current ratio of 1.731.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Aakaar Medical Techn has a ROE of 33.8078%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Aakaar Medical Techn has a Debt to Equity ratio of 0.98 which means that the company has low proportion of debt in its capital.

  • Sales growth: Aakaar Medical Techn has reported revenue growth of 33.5534% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Aakaar Medical Techn for the current financial year is 15.8109082406126%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Aakaar Medical Techn is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Aakaar Medical Techn is Rs 4.2613. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Aakaar Medical Techn in Ticker for free. Also, one can get the intrinsic value of Aakaar Medical Techn by using Valuation Calculators, which are available with a Finology ONE subscription. 

Aakaar Medical Techn FAQs

Q1. What is Aakaar Medical Techn share price today?
Ans: The current share price of Aakaar Medical Techn is Rs 92.55.

Q2. What is the market capitalisation of Aakaar Medical Techn?
Ans: Aakaar Medical Techn has a market capitalisation of Rs 131.16941208 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Aakaar Medical Techn?
Ans: The PE ratio of Aakaar Medical Techn is 21.71872433295 and the P/B ratio of Aakaar Medical Techn is 2.61264287670189, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Aakaar Medical Techn share?
Ans: The 52-week high share price of Aakaar Medical Techn is Rs 105, and the 52-week low share price of Aakaar Medical Techn is Rs 62.

Q5. Does Aakaar Medical Techn pay dividends?
Ans: Currently, Aakaar Medical Techn does not pay dividends. Dividend yield of Aakaar Medical Techn is around 0%.

Q6. What are the face value and book value of Aakaar Medical Techn shares?
Ans: The face value of Aakaar Medical Techn shares is Rs 10, while the book value per share of Aakaar Medical Techn is around Rs 35.4239. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Aakaar Medical Techn?
Ans: Aakaar Medical Techn has a total debt of Rs 22.7383 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Aakaar Medical Techn?
Ans: The ROE of Aakaar Medical Techn is 33.8078% and ROCE of Aakaar Medical Techn is 26.6249%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Aakaar Medical Techn a good buy for the long term?
Ans: The Aakaar Medical Techn long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Aakaar Medical Techn undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Aakaar Medical Techn appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Aakaar Medical Techn’s financials?
Ans: You can review Aakaar Medical Techn’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Aakaar Medical Techn
X